Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

An Overview of Recent Findings that Shed Light on the Connection between Fat and Cancer

Author(s): Parth Pandit, Chaitanya Shirke, Nirav Bhatia, Angel Godad, Sateesh Belemkar, Jayshree Patel and Sandip Zine*

Volume 24, Issue 2, 2024

Published on: 29 August, 2023

Page: [178 - 193] Pages: 16

DOI: 10.2174/1871530323666230724141942

Price: $65

conference banner
Abstract

Obesity and cancer have been found to have a direct link in epidemiological studies. Obesity raises the risk of cancer and associated chronic disorders. Furthermore, an imbalance of adipokines, like leptins, plays a crucial role in neoplasm pathogenesis, cell migration, and thereby, cancer metastasis. Also, leptin increases human epidermal growth factor receptor 2 (HER2) protein levels through the STAT3-mediated (signal transducer and activator of transcription) upregulation of heat shock protein (Hsp90) in breast cancer cells. It has been noticed that insulin and insulin-like growth factors (IGFs) act as mitosis activators in the host and cancerous breast epithelial cells. The condition of hyperinsulinemia explains the positive association between colorectal cancer and obesity. Furthermore, in prostate cancer, an alteration in sex hormone levels, testosterone and dihydrotestosterone, has been reported to occur, along with increased oxidative stress, which is the actual cause of the tumors. Whereas, there have been two interconnected factors that play a crucial role in the psychological cycle concerned with lung cancer. The review article focuses on all the prospects of etiological mechanisms that have found linkage with obesity and breast, colon, lung, and prostate cancers. Furthermore, the article has also highlighted how these new insights into the processes occur and, due to which reasons, obesity contributes to tumorigenesis. This review provides a detailed discussion on the progression, which can assist in the development of new and innovative techniques to interfere in this process, and it has been supported with insights based on evidence literature on approved clinical treatments for obesity and cancer.

Keywords: Obesity, epidemiology, body mass index, cancer, etiological mechanisms, leptins, STAT3-mediated, clinical trials.

« Previous Next »
Graphical Abstract

[1]
Lowe, S.W.; Lin, A.W. Apoptosis in cancer. Carcinogenesis, 2000, 21(3), 485-495.
[http://dx.doi.org/10.1093/carcin/21.3.485] [PMID: 10688869]
[2]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[3]
Bertram, J.S. The molecular biology of cancer. Mol. Aspects Med., 2000, 21(6), 167-223.
[http://dx.doi.org/10.1016/S0098-2997(00)00007-8] [PMID: 11173079]
[4]
Sankari, S.L.; Masthan, K.M.K.; Babu, N.A.; Bhattacharjee, T.; Elumalai, M. Apoptosis in cancer-An update. Asian Pac. J. Cancer Prev., 2012, 13(10), 4873-4878.
[http://dx.doi.org/10.7314/APJCP.2012.13.10.4873] [PMID: 23244073]
[5]
What is cancer? 2021. Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer
[6]
Organization, W.H. WHO | Cancer Factsheet; World Health Organization, 2017.
[7]
Ogden, C.L.; Yanovski, S.Z.; Carroll, M.D.; Flegal, K.M. The epidemiology of obesity. Gastroenterology, 2007, 132(6), 2087-2102.
[http://dx.doi.org/10.1053/j.gastro.2007.03.052] [PMID: 17498505]
[8]
Calle, E.E.; Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer, 2004, 4(8), 579-591.
[http://dx.doi.org/10.1038/nrc1408] [PMID: 15286738]
[9]
Islami, F.; Goding S., A.; Miller, K.D.; Siegel, R.L.; Fedewa, S.A.; Jacobs, E.J.; McCullough, M.L.; Patel, A.V.; Ma, J.; Soerjomataram, I.; Flanders, W.D.; Brawley, O.W.; Gapstur, S.M.; Jemal, A. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin, 2018, 68(1), 31-54.
[http://dx.doi.org/10.3322/caac.21440] [PMID: 29160902]
[10]
Kyrgiou, M.; Kalliala, I.; Markozannes, G.; Gunter, M.J.; Paraskevaidis, E.; Gabra, H.; Martin-Hirsch, P.; Tsilidis, K.K. Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ, 2017, 356, j477.
[http://dx.doi.org/10.1136/bmj.j477] [PMID: 28246088]
[11]
Kolb, R.; Kluz, P.; Tan, Z.W.; Borcherding, N.; Bormann, N. Vishwakarma, A Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene, 2019, 38(13), 2351-2363.
[http://dx.doi.org/10.1038/s41388-018-0592-6] [PMID: 30518876]
[12]
De Pergola, G.; Silvestris, F. Obesity as a major risk factor for cancer. J. Obes., 2013, 2013, 291546.
[http://dx.doi.org/10.1155/2013/291546] [PMID: 24073332]
[13]
Renehan, A.G.; Tyson, M.; Egger, M.; Heller, R.F.; Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 2008, 371(9612), 569-578.
[http://dx.doi.org/10.1016/S0140-6736(08)60269-X] [PMID: 18280327]
[14]
Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 2003, 348(17), 1625-1638.
[http://dx.doi.org/10.1056/NEJMoa021423] [PMID: 12711737]
[15]
Aleksandrova, K.; Nimptsch, K.; Pischon, T. Obesity and colorectal cancer. Gut, 2013, 62(6), 933-947.
[http://dx.doi.org/10.2741/E596] [PMID: 23481261]
[16]
Danaei, G.; Ding, E.L.; Mozaffarian, D.; Taylor, B.; Rehm, J.; Murray, C.J.L.; Ezzati, M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med., 2009, 6(4), e1000058.
[http://dx.doi.org/10.1371/journal.pmed.1000058] [PMID: 19399161]
[17]
Nitta, S.; Numata, K. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int. J. Mol. Sci., 2013, 14(1), 1629-1654.
[http://dx.doi.org/10.3390/ijms14011629] [PMID: 23344060]
[18]
Cypess, A.M.; White, A.P.; Vernochet, C.; Schulz, T.J.; Xue, R.; Sass, C.A.; Huang, T.L.; Roberts-Toler, C.; Weiner, L.S.; Sze, C.; Chacko, A.T.; Deschamps, L.N.; Herder, L.M.; Truchan, N.; Glasgow, A.L.; Holman, A.R.; Gavrila, A.; Hasselgren, P.O.; Mori, M.A.; Molla, M.; Tseng, Y.H. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med., 2013, 19(5), 635-639.
[http://dx.doi.org/10.1038/nm.3112] [PMID: 23603815]
[19]
Tchernof, A.; Després, J.P. Pathophysiology of human visceral obesity: An update. Physiol. Rev., 2013, 93(1), 359-404.
[http://dx.doi.org/10.1152/physrev.00033.2011] [PMID: 23303913]
[20]
Gesta, S.; Tseng, Y.H.; Kahn, C.R. Developmental origin of fat: tracking obesity to its source. Cell, 2007, 131(2), 242-256.
[http://dx.doi.org/10.1016/j.cell.2007.10.004] [PMID: 17956727]
[21]
Hafidi, M.E.; Buelna-Chontal, M.; Sánchez-Muñoz, F.; Carbó, R. Adipogenesis: A necessary but harmful strategy. Int. J. Mol. Sci., 2019, 20(15), 3657.
[http://dx.doi.org/10.3390/ijms20153657] [PMID: 31357412]
[22]
Kelly, T.; Yang, W.; Chen, C-S.; Reynolds, K.; He, J. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes., 2008, 32(9), 1431-1437.
[http://dx.doi.org/10.1038/ijo.2008.102] [PMID: 18607383]
[23]
Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F.; Abraham, J.P.; Abu-Rmeileh, N.M.E.; Achoki, T.; AlBuhairan, F.S.; Alemu, Z.A.; Alfonso, R.; Ali, M.K.; Ali, R.; Guzman, N.A.; Ammar, W.; Anwari, P.; Banerjee, A.; Barquera, S.; Basu, S.; Bennett, D.A.; Bhutta, Z.; Blore, J.; Cabral, N.; Nonato, I.C.; Chang, J.C.; Chowdhury, R.; Courville, K.J.; Criqui, M.H.; Cundiff, D.K.; Dabhadkar, K.C.; Dandona, L.; Davis, A.; Dayama, A.; Dharmaratne, S.D.; Ding, E.L.; Durrani, A.M.; Esteghamati, A.; Farzadfar, F.; Fay, D.F.J.; Feigin, V.L.; Flaxman, A.; Forouzanfar, M.H.; Goto, A.; Green, M.A.; Gupta, R.; Hafezi-Nejad, N.; Hankey, G.J.; Harewood, H.C.; Havmoeller, R.; Hay, S.; Hernandez, L.; Husseini, A.; Idrisov, B.T.; Ikeda, N.; Islami, F.; Jahangir, E.; Jassal, S.K.; Jee, S.H.; Jeffreys, M.; Jonas, J.B.; Kabagambe, E.K.; Khalifa, S.E.A.H.; Kengne, A.P.; Khader, Y.S.; Khang, Y.H.; Kim, D.; Kimokoti, R.W.; Kinge, J.M.; Kokubo, Y.; Kosen, S.; Kwan, G.; Lai, T.; Leinsalu, M.; Li, Y.; Liang, X.; Liu, S.; Logroscino, G.; Lotufo, P.A.; Lu, Y.; Ma, J.; Mainoo, N.K.; Mensah, G.A.; Merriman, T.R.; Mokdad, A.H.; Moschandreas, J.; Naghavi, M.; Naheed, A.; Nand, D.; Narayan, K.M.V.; Nelson, E.L.; Neuhouser, M.L.; Nisar, M.I.; Ohkubo, T.; Oti, S.O.; Pedroza, A.; Prabhakaran, D.; Roy, N.; Sampson, U.; Seo, H.; Sepanlou, S.G.; Shibuya, K.; Shiri, R.; Shiue, I.; Singh, G.M.; Singh, J.A.; Skirbekk, V.; Stapelberg, N.J.C.; Sturua, L.; Sykes, B.L.; Tobias, M.; Tran, B.X.; Trasande, L.; Toyoshima, H.; van de Vijver, S.; Vasankari, T.J.; Veerman, J.L.; Velasquez-Melendez, G.; Vlassov, V.V.; Vollset, S.E.; Vos, T.; Wang, C.; Wang, X.; Weiderpass, E.; Werdecker, A.; Wright, J.L.; Yang, Y.C.; Yatsuya, H.; Yoon, J.; Yoon, S.J.; Zhao, Y.; Zhou, M.; Zhu, S.; Lopez, A.D.; Murray, C.J.L.; Gakidou, E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014, 384(9945), 766-781.
[http://dx.doi.org/10.1016/S0140-6736(14)60460-8] [PMID: 24880830]
[24]
Harris, F.T.; Rahman, S.M.J.; Hassanein, M.; Qian, J.; Hoeksema, M.D.; Chen, H.; Eisenberg, R.; Chaurand, P.; Caprioli, R.M.; Shiota, M.; Massion, P.P. Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer. Cancer Prev. Res. (Phila.), 2014, 7(7), 748-757.
[http://dx.doi.org/10.1158/1940-6207.CAPR-14-0057] [PMID: 24819876]
[25]
Rodríguez-Enríquez, S.; Hernández-Esquivel, L.; Marín-Hernández, A.; El Hafidi, M.; Gallardo-Pérez, J.C.; Hernández-Reséndiz, I.; Rodríguez-Zavala, J.S.; Pacheco-Velázquez, S.C.; Moreno-Sánchez, R. Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells. Int. J. Biochem. Cell Biol., 2015, 65, 209-221.
[http://dx.doi.org/10.1016/j.biocel.2015.06.010] [PMID: 26073129]
[26]
Schlaepfer, I.R.; Rider, L.; Rodrigues, L.U.; Gijón, M.A.; Pac, C.T.; Romero, L.; Cimic, A.; Sirintrapun, S.J.; Glodé, L.M.; Eckel, R.H.; Cramer, S.D. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol. Cancer Ther., 2014, 13(10), 2361-2371.
[http://dx.doi.org/10.1158/1535-7163.MCT-14-0183] [PMID: 25122071]
[27]
Nieman, K.M.; Kenny, H.A.; Penicka, C.V.; Ladanyi, A.; Buell-Gutbrod, R.; Zillhardt, M.R.; Romero, I.L.; Carey, M.S.; Mills, G.B.; Hotamisligil, G.S.; Yamada, S.D.; Peter, M.E.; Gwin, K.; Lengyel, E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med., 2011, 17(11), 1498-1503.
[http://dx.doi.org/10.1038/nm.2492] [PMID: 22037646]
[28]
Nieman, K.M.; Romero, I.L.; Van Houten, B.; Lengyel, E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2013, 1831(10), 1533-1541.
[http://dx.doi.org/10.1016/j.bbalip.2013.02.010] [PMID: 23500888]
[29]
Hursting, S.D.; Dunlap, S.M. Obesity, metabolic dysregulation, and cancer: A growing concern and an inflammatory (and microenvironmental) issue. Ann. N. Y. Acad. Sci., 2012, 1271(1), 82-87.
[http://dx.doi.org/10.1111/j.1749-6632.2012.06737.x] [PMID: 23050968]
[30]
Saxena, N.K.; Vertino, P.M.; Anania, F.A.; Sharma, D. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J. Biol. Chem., 2007, 282(18), 13316-13325.
[http://dx.doi.org/10.1074/jbc.M609798200] [PMID: 17344214]
[31]
Nimri, L.; Saadi, J.; Peri, I.; Yehuda-Shnaidman, E.; Schwartz, B. Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis. Oncotarget, 2015, 6(35), 38195-38209.
[http://dx.doi.org/10.18632/oncotarget.5561] [PMID: 26472027]
[32]
Onuma, M.; Bub, J.D.; Rummel, T.L.; Iwamoto, Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J. Biol. Chem., 2003, 278(43), 42660-42667.
[http://dx.doi.org/10.1074/jbc.M304984200] [PMID: 12902351]
[33]
Garofalo, C.; Surmacz, E. Leptin and cancer. J. Cell. Physiol., 2006, 207(1), 12-22.
[http://dx.doi.org/10.1002/jcp.20472] [PMID: 16110483]
[34]
Fazolini, N.P.B.; Cruz, A.L.S.; Werneck, M.B.F.; Viola, J.P.B.; Maya-Monteiro, C.M.; Bozza, P.T. Leptin activation of mTOR pathway in intestinal epithelial cell triggers lipid droplet formation, cytokine production and increased cell proliferation. Cell Cycle, 2015, 14(16), 2667-2676.
[http://dx.doi.org/10.1080/15384101.2015.1041684] [PMID: 26017929]
[35]
Grossmann, M.E.; Nkhata, K.J.; Mizuno, N.K.; Ray, A.; Cleary, M.P. Effects of adiponectin on breast cancer cell growth and signaling. Br. J. Cancer, 2008, 98(2), 370-379.
[http://dx.doi.org/10.1038/sj.bjc.6604166] [PMID: 18182989]
[36]
Cong, L.; Gasser, J.; Zhao, J.; Yang, B.; Li, F.; Zhao, A.Z. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95–2. Endocr. Relat. Cancer, 2007, 14(3), 713-720.
[http://dx.doi.org/10.1677/ERC-07-0065] [PMID: 17914101]
[37]
Nomura, D.K.; Long, J.Z.; Niessen, S.; Hoover, H.S.; Ng, S.W.; Cravatt, B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 2010, 140(1), 49-61.
[http://dx.doi.org/10.1016/j.cell.2009.11.027] [PMID: 20079333]
[38]
Dorak, M.T.; Karpuzoglu, E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front. Genet., 2012, 3(NOV), 268.
[http://dx.doi.org/10.3389/fgene.2012.00268] [PMID: 23226157]
[39]
Annett, S.; Moore, G.; Robson, T. Obesity and cancer metastasis: Molecular and translational perspectives. Cancers (Basel), 2020, 12(12), 3798.
[http://dx.doi.org/10.3390/cancers12123798] [PMID: 33339340]
[40]
Louie, S.M.; Roberts, L.S.; Nomura, D.K. Mechanisms linking obesity and cancer. Biochim Biophys Acta -. Mol. Cell. Biol., 2013, 1831(10), 1499-1508.
[41]
Cao, H.; Sekiya, M.; Ertunc, M.E.; Burak, M.F.; Mayers, J.R.; White, A.; Inouye, K.; Rickey, L.M.; Ercal, B.C.; Furuhashi, M.; Tuncman, G.; Hotamisligil, G.S. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab., 2013, 17(5), 768-778.
[http://dx.doi.org/10.1016/j.cmet.2013.04.012] [PMID: 23663740]
[42]
Brandon, J.A.; Kraemer, M.; Vandra, J.; Halder, S.; Ubele, M.; Morris, A.J.; Smyth, S.S. Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity. PLoS One, 2019, 14(2), e0208099.
[http://dx.doi.org/10.1371/journal.pone.0208099] [PMID: 30730895]
[43]
Wu, T.; Vander Kooi, C.; Shah, P.; Charnigo, R.; Huang, C.; Smyth, S.S.; Morris, A.J. Integrin‐mediated cell surface recruitment of autotaxin promotes persistent directional cell migration. FASEB J., 2014, 28(2), 861-870.
[http://dx.doi.org/10.1096/fj.13-232868] [PMID: 24277575]
[44]
Cha, Y.J.; Koo, J.S. Adipokines as therapeutic targets in breast cancer treatment. Expert Opin. Ther. Targets, 2018, 22(11), 941-953.
[http://dx.doi.org/10.1080/14728222.2018.1538356] [PMID: 30332900]
[45]
Booth, A.; Magnuson, A.; Fouts, J.; Foster, M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm. Mol. Biol. Clin. Investig., 2015, 21(1), 57-74.
[http://dx.doi.org/10.1515/hmbci-2014-0037] [PMID: 25781552]
[46]
Pérez-Hernández, A.I.; Catalán, V.; Gómez-Ambrosi, J. Mechanisms linking excess adiposity and carcinogenesis promotion. Front. Endocrinol. (Lausanne), 2014, 5, 65.
[http://dx.doi.org/10.3389/fendo.2014.00065] [PMID: 24829560]
[47]
Scherer, P.E.; Williams, S.; Fogliano, M.; Baldini, G.; Lodish, H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270(45), 26746-26749.
[http://dx.doi.org/10.1074/jbc.270.45.26746] [PMID: 7592907]
[48]
Ouchi, N.; Kihara, S.; Arita, Y.; Okamoto, Y.; Maeda, K.; Kuriyama, H.; Hotta, K.; Nishida, M.; Takahashi, M.; Muraguchi, M.; Ohmoto, Y.; Nakamura, T.; Yamashita, S.; Funahashi, T.; Matsuzawa, Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 2000, 102(11), 1296-1301.
[http://dx.doi.org/10.1161/01.CIR.102.11.1296] [PMID: 10982546]
[49]
Scully, T.; Ettela, A.; LeRoith, D.; Gallagher, E. J. Obesity, type 2 diabetes, and cancer risk. Front. Oncol., 2021, 10, 615375.
[http://dx.doi.org/10.3389/fonc.2020.615375] [PMID: 33604295]
[50]
Hopkins, B.D.; Goncalves, M.D.; Cantley, L.C. Obesity and cancer mechanisms: Cancer metabolism. J. Clin. Oncol., 2016, 34(35), 4277-4283.
[http://dx.doi.org/10.1200/JCO.2016.67.9712] [PMID: 27903152]
[51]
Vucenik, I.; Stains, J.P. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci., 2012, 1271(1), 37-43.
[http://dx.doi.org/10.1111/j.1749-6632.2012.06750.x] [PMID: 23050962]
[52]
Sridhar, S.S.; Goodwin, P.J. Insulin-insulin-like growth factor axis and colon cancer. J. Clin. Oncol., 2009, 27(2), 165-167.
[http://dx.doi.org/10.1200/JCO.2008.19.8937] [PMID: 19064959]
[53]
Basen-Engquist, K.; Chang, M. Obesity and cancer risk: recent review and evidence. Curr. Oncol. Rep., 2011, 13(1), 71-76.
[http://dx.doi.org/10.1007/s11912-010-0139-7] [PMID: 21080117]
[54]
Law, J.H.; Habibi, G.; Hu, K.; Masoudi, H.; Wang, M.Y.C.; Stratford, A.L.; Park, E.; Gee, J.M.W.; Finlay, P.; Jones, H.E.; Nicholson, R.I.; Carboni, J.; Gottardis, M.; Pollak, M.; Dunn, S.E. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res., 2008, 68(24), 10238-10246.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-2755] [PMID: 19074892]
[55]
Mulligan, A.M.; O’Malley, F.P.; Ennis, M.; Fantus, I.G.; Goodwin, P.J. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res. Treat., 2007, 106(1), 39-47.
[http://dx.doi.org/10.1007/s10549-006-9471-x] [PMID: 17221153]
[56]
Yager, J.D.; Davidson, N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 2006, 354(3), 270-282.
[http://dx.doi.org/10.1056/NEJMra050776] [PMID: 16421368]
[57]
Zoncu, R.; Efeyan, A. Sabatini, DM mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol., 2010, 12(1), 21-35.
[http://dx.doi.org/10.1038/nrm3025] [PMID: 21157483]
[58]
Li, J.; Jia, H.; Cai, X.; Zhong, H.; Feng, Q.; Sunagawa, S. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol., 2014, 32(8), 834-841.
[http://dx.doi.org/10.1038/nbt.2942] [PMID: 24997786]
[59]
Rogers, C.J.; Prabhu, K.S.; Vijay-Kumar, M. The microbiome and obesity-an established risk for certain types of cancer. Cancer J., 2014, 20(3), 176-180.
[http://dx.doi.org/10.1097/PPO.0000000000000049] [PMID: 24855004]
[60]
Avgerinos, K.I.; Spyrou, N.; Mantzoros, C.S.; Dalamaga, M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism, 2019, 92, 121-135.
[http://dx.doi.org/10.1016/j.metabol.2018.11.001] [PMID: 30445141]
[61]
Zhang, Z.; Zhang, L.; Zhang, Q.; Liu, B.; Li, F.; Xin, Y. HO-1/CO maintains intestinal barrier integrity through NF-κB/MLCK pathway in intestinal HO-1-/- mice. Oxid. Med. Cell. Longev., 2021, 2021, 6620873.
[http://dx.doi.org/10.1155/2021/6620873] [PMID: 34104309]
[62]
Zhang, H.; Chang, Y.; Zheng, Q.; Zhang, R.; Hu, C.; Jia, W. Altered intestinal microbiota associated with colorectal cancer. Front. Med., 2019, 13(4), 461-470.
[http://dx.doi.org/10.1007/s11684-019-0695-7] [PMID: 31250341]
[63]
Berger, N.A. Obesity and cancer pathogenesis. Ann. N. Y. Acad. Sci., 2014, 1311(1), 57-76.
[http://dx.doi.org/10.1111/nyas.12416] [PMID: 24725147]
[64]
Hossain, F.; Majumder, S.; David, J.; Bunnell, B.A.; Miele, L. Obesity modulates the gut microbiome in triple-negative breast cancer. Nutrients, 2021, 13(10), 3656.
[http://dx.doi.org/10.3390/nu13103656] [PMID: 34684657]
[65]
Yu, L.X.; Schwabe, R.F. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat. Rev. Gastroenterol. Hepatol., 2017, 14(9), 527-539.
[http://dx.doi.org/10.1038/nrgastro.2017.72] [PMID: 28676707]
[66]
Moore, L.L.; Chadid, S.; Singer, M.R.; Kreger, B.E.; Denis, G.V. Metabolic health reduces risk of obesity-related cancer in framingham study adults. Cancer Epidemiol. Biomarkers Prev., 2014, 23(10), 2057-2065.
[http://dx.doi.org/10.1158/1055-9965.EPI-14-0240] [PMID: 25012997]
[67]
Britton, K.A.; Fox, C.S. Ectopic fat depots and cardiovascular disease. Circulation, 2011, 124(24), e837-e841.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.077602] [PMID: 22156000]
[68]
Coe, P.O.; O’Reilly, D.A.; Renehan, A.G. Excess adiposity and gastrointestinal cancer. Br. J. Surg., 2014, 101(12), 1518-1531.
[http://dx.doi.org/10.1002/bjs.9623] [PMID: 25224741]
[69]
Stienstra, R.; van Diepen, J.A.; Tack, C.J.; Zaki, M.H.; van de Veerdonk, F.L.; Perera, D.; Neale, G.A.; Hooiveld, G.J.; Hijmans, A.; Vroegrijk, I.; van den Berg, S.; Romijn, J.; Rensen, P.C.N.; Joosten, L.A.B.; Netea, M.G.; Kanneganti, T.D. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 2011, 108(37), 15324-15329.
[http://dx.doi.org/10.1073/pnas.1100255108] [PMID: 21876127]
[70]
Mauro, L.; Naimo, G.D.; Ricchio, E.; Panno, M.L.; Andò, S. Crosstalk between adiponectin and IGF-IR in breast cancer. Front. Oncol., 2015, 5, 157.
[PMID: 26236690]
[71]
Fukumura, D.; Incio, J.; Shankaraiah, R.C.; Jain, R.K. Obesity and Cancer: An Angiogenic and Inflammatory Link. Microcirculation, 2016, 23(3), 191-206.
[http://dx.doi.org/10.1111/micc.12270] [PMID: 26808917]
[72]
Fukumura, D.; Ushiyama, A.; Duda, D.G.; Xu, L.; Tam, J.; Krishna, V.; Chatterjee, K.; Garkavtsev, I.; Jain, R.K. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res., 2003, 93(9), e88-e97.
[http://dx.doi.org/10.1161/01.RES.0000099243.20096.FA] [PMID: 14525808]
[73]
Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol., 2014, 15(3), 178-196.
[http://dx.doi.org/10.1038/nrm3758] [PMID: 24556840]
[74]
Pastushenko, I.; Brisebarre, A.; Sifrim, A.; Fioramonti, M.; Revenco, T.; Boumahdi, S. Identification of the tumour transition states occurring during EMT. Nature, 2018, 556(7702), 463-468.
[http://dx.doi.org/10.1038/s41586-018-0040-3] [PMID: 29670281]
[75]
Rankin, E.B.; Giaccia, A.J. Hypoxic control of metastasis. Science, 2016, 352(6282), 175-180.
[http://dx.doi.org/10.1126/science.aaf4405] [PMID: 27124451]
[76]
Hursting, S.D.; DiGiovanni, J.; Dannenberg, A.J.; Azrad, M.; LeRoith, D.; Demark-Wahnefried, W.; Kakarala, M.; Brodie, A.; Berger, N.A. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev. Res. (Phila.), 2012, 5(11), 1260-1272.
[http://dx.doi.org/10.1158/1940-6207.CAPR-12-0140] [PMID: 23034147]
[77]
Lin, J.H.; Walter, P.; Yen, T.S.B. Endoplasmic reticulum stress in disease pathogenesis. Annu. Rev. Pathol., 2008, 3(1), 399-425.
[http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151434] [PMID: 18039139]
[78]
Corazzari, M.; Gagliardi, M.; Fimia, G.M.; Piacentini, M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front. Oncol., 2017, 7, 78.
[http://dx.doi.org/10.3389/fonc.2017.00078] [PMID: 28491820]
[79]
de Martel, C.; Georges, D.; Bray, F.; Ferlay, J.; Clifford, G.M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health, 2020, 8(2), e180-e190.
[http://dx.doi.org/10.1016/S2214-109X(19)30488-7] [PMID: 31862245]
[80]
Lorincz, A.M.; Sukumar, S. Molecular links between obesity and breast cancer. Endocr. Relat. Cancer, 2006, 13(2), 279-292.
[http://dx.doi.org/10.1677/erc.1.00729] [PMID: 16728564]
[81]
Mohanty, S.S.; Sahoo, C.R.; Padhy, R.N. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update. Genes Dis., 2022, 9(3), 648-658.
[http://dx.doi.org/10.1016/j.gendis.2020.12.005] [PMID: 35782984]
[82]
Stephenson, G.D.; Rose, D.P. Breast cancer and obesity: an update. Nutr. Cancer, 2003, 45(1), 1-16.
[http://dx.doi.org/10.1207/S15327914NC4501_1] [PMID: 12791499]
[83]
Agurs-Collins, T.; Ross, S.A.; Dunn, B.K. The many faces of obesity and its influence on breast cancer risk. Front. Oncol., 2019, 9(September), 765.
[http://dx.doi.org/10.3389/fonc.2019.00765] [PMID: 31555578]
[84]
Cleary, M.P.; Grossmann, M.E. Minireview: Obesity and breast cancer: The estrogen connection. Endocrinology, 2009, 150(6), 2537-2542.
[http://dx.doi.org/10.1210/en.2009-0070] [PMID: 19372199]
[85]
Christopoulos, P.F.; Msaouel, P.; Koutsilieris, M. The role of the insulin-like growth factor-1 system in breast cancer. Mol. Cancer, 2015, 14(1), 43.
[http://dx.doi.org/10.1186/s12943-015-0291-7] [PMID: 25743390]
[86]
Quénéhervé, L.; Reboux, N.; Noël, C.; Robaszkiewicz, M. Obesity and colorectal cancer. Hepato-Gastro. Oncol. Dig., 2021, 28(1), 46-53.
[87]
Singh, S.; Mayengbam, S.S.; Chouhan, S.; Deshmukh, B.; Ramteke, P.; Athavale, D.; Bhat, M.K. Role of TNFα and leptin signaling in colon cancer incidence and tumor growth under obese phenotype. Biochim. Biophys. Acta Mol. Basis Dis., 2020, 1866(5), 165660.
[http://dx.doi.org/10.1016/j.bbadis.2019.165660] [PMID: 31891805]
[88]
Johnson, I.T.; Lund, E.K. Review article: Nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther., 2007, 26(2), 161-181.
[http://dx.doi.org/10.1111/j.1365-2036.2007.03371.x] [PMID: 17593063]
[89]
Tilg, H.; Adolph, T.E.; Gerner, R.R.; Moschen, A.R. The intestinal microbiota in colorectal cancer. Cancer Cell, 2018, 33(6), 954-964.
[http://dx.doi.org/10.1016/j.ccell.2018.03.004] [PMID: 29657127]
[90]
Allott, E.H.; Masko, E.M.; Freedland, S.J. Obesity and prostate cancer: weighing the evidence. Eur. Urol., 2013, 63(5), 800-809.
[http://dx.doi.org/10.1016/j.eururo.2012.11.013] [PMID: 23219374]
[91]
Bandini, M.; Gandaglia, G.; Briganti, A. Obesity and prostate cancer. Curr. Opin. Urol., 2017, 27(5), 415-421.
[http://dx.doi.org/10.1097/MOU.0000000000000424] [PMID: 28632505]
[92]
Taylor, R.A.; Lo, J.; Ascui, N.; Watt, M.J. Linking obesogenic dysregulation to prostate cancer progression. Endocr. Connect., 2015, 4(4), R68-R80.
[http://dx.doi.org/10.1530/EC-15-0080] [PMID: 26581226]
[93]
Parikesit, D.; Mochtar, C.A.; Umbas, R.; Hamid, A.R.A.H. The impact of obesity towards prostate diseases. Prostate Int., 2016, 4(1), 1-6.
[http://dx.doi.org/10.1016/j.prnlm.2015.08.001] [PMID: 27014656]
[94]
Mafort, T.T.; Rufino, R.; Costa, C.H.; Lopes, A. J. Obesity: Systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip. Respir. Med., 2016, 11, 28.
[http://dx.doi.org/10.1186/s40248-016-0066-z] [PMID: 27408717]
[95]
Carmichael, A.R. Obesity and prognosis of breast cancer. Obes. Rev., 2006, 7(4), 333-340.
[http://dx.doi.org/10.1111/j.1467-789X.2006.00261.x] [PMID: 17038127]
[96]
Tapia, E.; Villa-Guillen, D.E.; Chalasani, P.; Centuori, S.; Roe, D.J.; Guillen-Rodriguez, J.; Huang, C.; Galons, J.P.; Thomson, C.A.; Altbach, M.; Trujillo, J.; Pinto, L.; Martinez, J.A.; Algotar, A.M.; Chow, H.H.S. A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density. Breast Cancer Res. Treat., 2021, 190(1), 69-78.
[http://dx.doi.org/10.1007/s10549-021-06355-9] [PMID: 34383179]
[97]
Zell, J.A.; McLaren, C.E.; Morgan, T.R.; Lawson, M.J.; Rezk, S.; Albers, C.G.; Chen, W.P.; Carmichael, J.C.; Chung, J.; Richmond, E.; Rodriguez, L.M.; Szabo, E.; Ford, L.G.; Pollak, M.N.; Meyskens, F.L. A phase IIa trial of metformin for colorectal cancer risk reduction among individuals with history of colorectal adenomas and elevated body mass index. Cancer Prev. Res. (Phila.), 2020, 13(2), 203-212.
[http://dx.doi.org/10.1158/1940-6207.CAPR-18-0262] [PMID: 31818851]
[98]
Bilusic, M.; Toney, N.J.; Donahue, R.N.; Wroblewski, S.; Zibelman, M.; Ghatalia, P.; Ross, E.A.; Karzai, F.; Madan, R.A.; Dahut, W.L.; Gulley, J.L.; Schlom, J.; Plimack, E.R.; Geynisman, D.M. A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer Prostatic Dis., 2022, 25(4), 735-740.
[http://dx.doi.org/10.1038/s41391-022-00492-y] [PMID: 35079115]
[99]
Greenway, F.L.; Aronne, L.J.; Raben, A.; Astrup, A.; Apovian, C.M.; Hill, J.O.; Kaplan, L.M.; Fujioka, K.; Matejkova, E.; Svacina, S.; Luzi, L.; Gnessi, L.; Navas-Carretero, S.; Alfredo Martinez, J.; Still, C.D.; Sannino, A.; Saponaro, C.; Demitri, C.; Urban, L.E.; Leider, H.; Chiquette, E.; Ron, E.S.; Zohar, Y.; Heshmati, H.M. A randomized, double‐blind, placebo‐controlled study of gelesis100: A novel nonsystemic oral hydrogel for weight loss. Obesity (Silver Spring), 2019, 27(2), 205-216.
[http://dx.doi.org/10.1002/oby.22347] [PMID: 30421844]
[100]
Clément, K.; van den Akker, E.; Argente, J.; Bahm, A.; Chung, W.K.; Connors, H.; De Waele, K.; Farooqi, I.S.; Gonneau-Lejeune, J.; Gordon, G.; Kohlsdorf, K.; Poitou, C.; Puder, L.; Swain, J.; Stewart, M.; Yuan, G.; Wabitsch, M.; Kühnen, P.; Pigeon-Kherchiche, P.; Flaus-Furmaniuk, A.; Bald, M.; Denzer, C.; von Schnurbein, J.; Abawi, O.; Blume-Peytavi, U.; Krabusch, P.; Mai, K.; Schnabel, D.; Wiegand, S.; Flück, C.E.; Schulz, E.; Voss, E.; Bratina, N.; Weiss, K.; Martos-Moreno, G.Á.; Danset, A.; Gougis, P.; Dubern, B.; Clément, K.; van den Akker, E.L.T.; Argente, J.; Bahm, A.L.; Chung, W.K.; Connors, H.S.; De Waele, K.; Farooqi, I.S.; Gonneau-Lejeune, J.; Gordon, G.A.; Poitou, C.; Puder, L.; Swain, J.M.; Stewart, M.W.; Yuan, G.; Wabitsch, M.; Kühnen, P. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: Single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol., 2020, 8(12), 960-970.
[http://dx.doi.org/10.1016/S2213-8587(20)30364-8] [PMID: 33137293]
[101]
Singh, G.; Krauthamer, M.; Bjalme-Evans, M. Wegovy (semaglutide): A new weight loss drug for chronic weight management. J. Investig. Med., 2022, 70(1), 5-13.
[http://dx.doi.org/10.1136/jim-2021-001952] [PMID: 34706925]

Rights & Permissions Print Cite
Article Metrics
34
3
Wayfinder Image
World Diabetes Day
© 2024 Bentham Science Publishers | Privacy Policy